Inhibikase Therapeutics (IKT) Receivables (2021 - 2023)
Inhibikase Therapeutics (IKT) reported Receivables of $79604.0 for Q2 2023, up 1114.96% year-over-year from $6552.0 in Q2 2022, and up 23.38% quarter-over-quarter from $64521.0 in Q1 2023.
Inhibikase Therapeutics (IKT) Receivables (2021 - 2023) Analysis & Trends
Inhibikase Therapeutics (IKT) has 3 years of Receivables data on file, last reported at $79604.0 in Q2 2023.
- Receivables for Q2 2023 came in at $79604.0, up 1114.96% year-over-year; the trailing twelve-month figure through Jun 2023 was $79604.0 (up 1114.96% YoY), and the FY2022 annual result was $39881.0, down 63.79% from the prior year.
- Receivables advanced to $79604.0 in Q2 2023 per IKT's latest filing, from $64521.0 in the prior quarter.
- Over five years, Receivables peaked at $110141.0 in Q4 2021 and troughed at $6552.0 in Q2 2022.
- A 3-year average of $51788.1 and a median of $47976.0 in 2022 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2023: Receivables sank 63.79% in 2022, then soared 1114.96% in 2023.
- A 3-year view of Receivables shows it stood at $110141.0 in 2021, then slumped by 63.79% to $39881.0 in 2022, then jumped by 99.6% to $79604.0 in 2023.
- Business Quant data shows IKT's Receivables at $79604.0 in Q2 2023, $64521.0 in Q1 2023, and $39881.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Inhibikase Therapeutics | 285.17 Mn | 114.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 79,604.00 |
| Mar 31, 2023 | 64,521.00 |
| Dec 31, 2022 | 39,881.00 |
| Sep 30, 2022 | 13,842.00 |
| Jun 30, 2022 | 6,552.00 |
| Mar 31, 2022 | 47,976.00 |
| Dec 31, 2021 | 110,141.00 |